Peptide record

TPDB45059

Antiviral standard
35 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB45059
Antiviral
Anti-infective peptides
AVPpred-BWR
standard
No
A 35-aa standard-residue antiviral peptide sequence curated from AVPpred-BWR, with an available 3D structural model.
Sequence
WQEWEREITALLEQAQIQQEKNEYELQKLIEWEWF
Physicochemical Analysis

Sequence-only estimates for a linear peptide with free termini, not experimentally measured molecular properties. Mass and formula exclude cyclization and disulfide formation. The optical estimates assume paired cysteines, 280 nm, 1 g/L and a 1 cm path. The N-end rule estimate is not a measured plasma half-life.

C211H307N51O63
DCGHMPSV
E
4566.06
3.95
3
9
15
-6
2.27
-1.109
83.71
Mammalian: 2.8 hour Yeast: 3 min E.coli: 2 min
23490
5.14
9
Residue Composition
number
2
A
1
R
1
N
0
D
0
C
9
E
6
Q
0
G
0
H
3
I
4
L
2
K
0
M
1
F
0
P
0
S
1
T
4
W
1
Y
0
V
Amino Acid Distribution
A: 2 R: 1 N: 1 D: 0 C: 0 E: 9 Q: 6 G: 0 H: 0 I: 3 L: 4 K: 2 M: 0 F: 1 P: 0 S: 0 T: 1 W: 4 Y: 1 V: 0
Chemical Descriptors
35 reviewed residue count
C211H307N51O63 sequence-only estimate (linear, free termini)
4566.06 sequence-only estimate (linear, free termini)
3.95 sequence-only estimate (linear, free termini)
-6 sequence-only estimate (linear, free termini)
2.27 sequence-only estimate (linear, free termini)
-1.109 sequence-only estimate (linear, free termini)
Evidence Records 1 records
Evidence 1 Activity

Source & Reference

NA